Functional medicine often focuses on nutrition, exercise, and stress management as the foundational pillars of health. But what other powerful environmental inputs could be leveraged with greater precision? What if heat and light could be used as biological inputs in a way that is measurable and clinically relevant?
Did you know that 1 in 3 older dolphins develops the same aging-associated conditions as humans? While continually helping to improve the health of older Navy dolphins living in San Diego Bay, veterinarians found that some dolphins had elevated cholesterol, insulin resistance, chronic inflammation, and fatty liver disease – just like some of us.
Age-related declines in muscle function, immune resilience, and cellular energy are closely linked to mitochondrial dysfunction, making mitochondrial-targeted interventions a key focus of aging research. In this context, recent placebo-controlled human trials show that a Urolithin A dose of 1000 mg produces broader and more pronounced effects on mitochondrial gene expression, muscle performance, and immune markers than lower doses.
In recent years, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) use has increased 700% in the general population and over one quarter of those diagnosed with diabetes are on these medications.
Can Mitopure®, and its active ingredient Urolithin A, support an aging immune system? As we recognize immune aging as a primary driver of age-related disease, this question has taken on new clinical importance. The newly published MitoImmune study in Nature Aging provides the first rigorous clinical evidence to address this question. Conducted by researchers from Timeline, the Buck Institute for Research on Aging, and the lab of Professor.
As functional medicine practitioners, we know that nutrition and lifestyle are among the most powerful levers for preventing and reversing all chronic disease, from cardiovascular disease and hypertension to cancer and type 2 diabetes. Yet we also see firsthand how challenging it can be for patients to translate recommendations into sustained daily practice. Deeply ingrained habits don’t shift overnight. In fact, a meta-analysis of 20 studies involving more than 2,600 participants found that health-related habits typically take 2–5 months to form, which is far longer than the popular “21-day” myth suggests.
Despite a dramatic rise in antidepressant use in the United States since 1988, the number of Americans suffering from depression has not decreased. This leaves clinicians with a stark reality: more medication, without improvement. This reality raises the central question that inspired the Healing Depression Project: Is depression truly treatment-resistant, or are current treatments simply not effective?
Osteoarthritis (OA) is a debilitating, chronic joint disease affecting about 33 million adults in the United States. As the aging population grows and obesity rates climb, this number is expected to surge. By 2030, nearly 67 million Americans will be living with arthritis, with OA being the most prevalent form. OA is not just a condition of the joints – it’s a systemic burden that increases the risk of serious comorbidities such as cardiovascular disease, type 2 diabetes, and depression, significantly impairing quality of life and increasing healthcare costs.
Urolithin A is rapidly becoming a go-to longevity nutrient, and with good reason. Backed by 15 years of research and 11 human clinical trials, it is one of the most extensively studied compounds for healthy aging.
Estrogen is a life-giving hormone with which modern humans have a complicated relationship. Over two decades ago, The Women’s Health Initiative (WHI) findings mistakenly reported that combined estrogen and progestin hormone therapy increased the risk of breast cancer, coronary heart disease, stroke, and venous thromboembolism in postmenopausal women. This led to a pervasive vilification of estrogen therapy that has affected generations of women.